Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
NEW Weight-Loss Drug: Retatrutide Revolutionizing Obesity Treatment? | Dr. Dan Obesity Expert Alli Slimming Tablets Reviews
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-27
Join this channel to get access to perks:
Download my FREE GLP-1/GIP Medication Information Sheet:
Subscribe to the channel:
Products I recommend to support your weight-loss journey:
Managing Constipation:
Managing Diarrhea:
Managing Heartburn:
Internalized Weight Bias:
Protein Bars:
Scales and More:
Supplements:
Activity Trackers I recommend:
My favorite Books:
In this captivating video, I delve deep into the revolutionary realm of obesity management with a spotlight on Retatrutide, a triple hormone receptor agonist poised to redefine the landscape of weight loss solutions. Join me on an enlightening journey as I unpack the intricacies of this innovative medication, exploring its unique mechanism of action and potential impact on individuals struggling with obesity.
Through meticulous analysis of a phase 2 clinical trial involving over 300 participants, I unveil compelling insights into Retatrutide's efficacy. From its ability to mimic three crucial satiety hormones—GLP-1, GIP, and GCG—to its remarkable outcomes in weight reduction percentages, this video offers a comprehensive overview of Retatrutide's transformative potential.
But my exploration doesn't stop there. I address important considerations such as side effects, including gastrointestinal discomfort and the emerging concern of cardiac arrhythmias. With balanced scrutiny, I navigate through the complexities of Retatrutide's safety profile, highlighting both its promises and potential challenges.
As we peer into the future, I discuss the ongoing phase 3 trials and the anticipated timeline for Retatrutide's availability in the market. Amidst the excitement of medical innovation, I underscore the significance of continued research and data dissemination, emphasizing the importance of informed decision-making in the realm of healthcare.
Watch my previous videos about how to fight obesity and about the best medicine for weight loss:
▪️ Watch This Before Taking Mounjaro:
▪️ From Ozempic to Mounjaro:
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro:
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!:
▪️ Ozempic: Stomach Paralysis Update:
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro:
▪️ Ozempic Paralyzed My Stomach:
▪️ How to Inject Mounjaro: step-by-step tutorial:
–
Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy -
–
Products to support your weight-loss journey:
USA:
Canada:
–
Sign up for my newsletter:
–
Contact Me: [email protected]
–
Have questions or need support on your weight-loss journey? Book a consultation with me:
–
For more about weight loss via habit mastery, visit
Join me on social media:
▪️
▪️
▪️ *NEW TIKTOK ACCOUNT:
#weightloss #obesity #obesitymedicine
NEW Weight-Loss Drug: Retatrutide Revolutionizing Obesity Treatment? | Dr. Dan Obesity Expert For Country: United States. City: Huntington Beach, Nashville, Rochester, Sacramento, Salinas
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication
